TrialRevista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)

Efficacy and safety of paliperidone palmitate 3-month formulation in Latin American patients with schizophrenia: A subgroup analysis of data from two large phase 3 randomized, double-blind studies.

Adam J Savitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.